Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill dataCNBC • 09/29/23
Structure Soars 32% As Newcomer Takes On Behemoths Lilly, Novo In Obesity TreatmentInvestors Business Daily • 09/29/23
Structure Therapeutics shares surge after positive results in weight-loss trial, $300 million private placementMarket Watch • 09/29/23
Structure Therapeutics Announces $300 Million Private Placement Equity FinancingGlobeNewsWire • 09/29/23
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program UpdateGlobeNewsWire • 09/29/23
Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent HighlightsGlobeNewsWire • 08/10/23
U.S. IPO Weekly Recap: July Closes Out With 2023's First Direct Listing And A Wave Of Small IPOsSeeking Alpha • 07/29/23
Buying Shares of These 2 Biotech Stocks Could Be a Brilliant Move in 5 YearsThe Motley Fool • 06/12/23
Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific SessionsGlobeNewsWire • 06/07/23
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and ObesityGlobeNewsWire • 05/25/23
Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International ConferenceGlobeNewsWire • 05/18/23
Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent HighlightsGlobeNewsWire • 05/11/23
Structure Therapeutics: Developing Innovative Treatments For Metabolic And Fibrotic DiseasesSeeking Alpha • 04/12/23
Structure Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent HighlightsGlobeNewsWire • 03/30/23
Structure Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary SharesGlobeNewsWire • 02/07/23
Structure Therapeutics IPO prices at top of range with larger number of shares added in a sign of healthy investor interestMarket Watch • 02/03/23